• Net Income from Continuing Operations: $17.4 million, or $0.46 per diluted share.

• Net Loss from Discontinued Operations: $(170.2) million, including significant losses on held for sale classification of JRG Re.

• Adjusted Net Operating Income: $12.4 million, or $0.33 per diluted share, reflecting strong investment income and underwriting results.

• Gross Written Premium: Increased by 8% to $389.3 million, with E&S segment exceeding $1.0 billion annually.

• Combined Ratio: Full year 2023 Group combined ratio of 96.5%, with E&S segment at 94.2% for Q4.

• Investment Income: Net investment income up 67.0% to $25.6 million in Q4 2023.

• Shareholders' Equity: Decreased 4.7% sequentially to $14.20 per share as of December 31, 2023.

• Warning! GuruFocus has detected 2 Warning Sign with JRVR.

On February 28, 2024, James River Group Holdings Ltd (NASDAQ:JRVR) released its 8-K filing, announcing its fourth quarter results for 2023. The company, which operates a group of specialty insurance and reinsurance companies, reported a net income from continuing operations of $17.4 million, or $0.46 per diluted share, compared to $23.2 million, or $0.60 per diluted share in the same period of 2022. However, the net loss available to common shareholders was $(152.8) million, or $(3.43) per diluted share, primarily due to a significant net loss from discontinued operations, including an $80.4 million loss on the held for sale classification of JRG Re.

The adjusted net operating income stood at $12.4 million, or $0.33 per diluted share, driven by strong investment income and profitable underwriting results, particularly from the Excess and Surplus Lines (E&S) segment. This segment wrote the largest annual and second largest quarterly amount of gross written premium in its history, exceeding $1.0 billion for the year, with a 12.1% growth in the fourth quarter compared to the prior year quarter.

Financial and Operational Highlights

The E&S segment's combined ratio was an impressive 94.2% for the fourth quarter, with renewal rates increasing by 11.0%, including 10.5% in casualty lines. The Specialty Admitted segment also performed well, with a combined ratio of 92.2% and fronting and program gross written premium growth of 12.5% compared to the prior year quarter, excluding the non-renewed California workers' compensation program.

Net investment income saw a significant increase of 67.0% in the fourth quarter compared to the prior year, with all asset classes reporting higher income. Shareholders' equity per share decreased by 4.7% sequentially from September 30, 2023, to $14.20, affected by the loss on sale of JRG Re, which was partially offset by net income from continuing operations and unrealized gains in the fixed maturity portfolio during the quarter.